J. K. Reddy, S. K. Goel, and M. R. Nemali, Transcription regulation of peroxisomal fatty acyl-CoA oxidase and enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase in rat liver by peroxisome proliferators, Proceedings of the National Acadamy of Sciences of the United States of America, vol.83, pp.1747-1751, 1986.

Y. Barak, M. C. Nelson, and E. S. Ong, PPAR is required for placental, cardiac, and adipose tissue development, Molecular Cell, vol.4, issue.4, pp.585-595, 1999.

K. Nadra, L. Quignodon, and C. Sardella, PPAR in placental angiogenesis, Endocrinology, vol.151, issue.10, pp.4969-4981, 2010.

N. Latruffe and J. Vamecq, Peroxisome proliferators and peroxisome proliferator activated receptors (PPARs) as regulators of lipid metabolism, Biochimie, vol.79, issue.2-3, pp.81-94, 1997.

K. Schoonjans, B. Staels, and J. Auwerx, The peroxisome proliferator activated receptors (PPARs) and their effects on lipid metabolism and adipocyte differentiation, Biochimica et Biophysica Acta-Lipids and Lipid Metabolism, vol.1302, issue.2, pp.93-109, 1996.

S. Giannini, M. Serio, and A. Galli, Pleiotropic effects of thiazolidinediones: Taking a look beyond antidiabetic activity, Journal of Endocrinological Investigation, vol.27, issue.10, pp.982-991, 2004.

A. Tarrade, K. Schoonjans, and J. Guibourdenche, PPAR / RXR heterodimers are involved in human CG synthesis and human trophoblast differentiation, Endocrinology, vol.142, issue.10, pp.4504-4514, 2001.

G. Krey, O. Braissant, and F. Horset, Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay, Molecular Endocrinology, vol.11, issue.6, pp.779-791, 1997.

R. K. Semple, V. K. Chatterjee, and S. O'rahilly, PPAR and human metabolic disease, The Journal of Clinical Investigation, vol.116, issue.3, pp.581-589, 2006.

B. Gross, M. Pawlak, P. Lefebvre, and B. Staels, PPARs in obesity-induced T2DM, dyslipidaemia and NAFLD, Nature Reviews Endocrinology, vol.13, issue.1, pp.36-49, 2016.

A. I. Abushouk, M. W. El-husseny, and E. I. Bahbah, Peroxisome proliferator-activated receptors as therapeutic targets for heart failure, Biomedicine & Pharmacotherapy, vol.95, pp.692-700, 2017.

M. Kvandova, M. Majzunova, and I. Dovinova, The role of PPARgamma in cardiovascular diseases, Physiol Res, vol.65, pp.343-363, 2016.

N. Wang, R. Yin, Y. Liu, G. Mao, and F. Xi, Role of peroxisome proliferator-activated receptor-in atherosclerosis: an update, Circulation Journal, vol.75, issue.3, pp.528-535, 2011.

O. Astapova and T. Leff, PPAR mutations, lipodystrophy and diabetes, Hormone Molecular Biology and Clinical Investigation, vol.20, issue.2, pp.63-70, 2014.

D. J. Graham, R. Ouellet-hellstrom, and T. E. Macurdy, Risk of acute myocardial infarction, stroke, heart failure, and death in elderly medicare patients treated with rosiglitazone or pioglitazone, Journal of the American Medical Association, vol.304, issue.4, pp.411-418, 2010.

F. Molnar, M. Matilainen, and C. Carlberg, Structural determinants of the agonist-independent association of human peroxisome proliferator-activated receptors with coactivators, The Journal of Biological Chemistry, vol.280, issue.28, pp.26543-26556, 2005.

J. Ma, T. Zhang, and N. Fang, Establishment of a cellbased drug screening model for identifying agonists of human peroxisome proliferator-activated receptor gamma (PPAR ), Journal of Pharmacy and Pharmacology, vol.64, issue.5, pp.719-726, 2012.

L. Gijsbers, H. Man, and S. K. Kloet, Stable reporter cell lines for peroxisome proliferator-activated receptor (PPAR )-mediated modulation of gene expression, Analytical Biochemistry, vol.414, issue.1, pp.77-83, 2011.

I. Punzon, V. Latapie, and S. L. Mével, Towards a humanized PPAR reporter system for in vivo screening of obesogens, Molecular and Cellular Endocrinology, vol.374, issue.1-2, pp.1-9, 2013.

I. G. Schulman, G. Shao, and R. A. Heyman, Transactivation by retinoid X receptor-peroxisome proliferator-activated receptor (PPAR ) heterodimers: Intermolecular synergy requires only the PPRA hormone-dependent activation function, Molecular and Cellular Biology, vol.18, issue.6, pp.3483-3494, 1998.

Q. Zhang, H. Seltmann, C. C. Zouboulis, and R. L. Konger, Involvement of PPAR in oxidative stress-mediated prostaglandin E2 production in SZ95 human sebaceous gland cells, Journal of Investigative Dermatology, vol.126, issue.1, pp.42-48, 2006.

A. Tarrade, K. Schoonjans, and L. Pavan, PPAR /RXR heterodimers control human trophoblast invasion, The Journal of Clinical Endocrinology & Metabolism, vol.86, issue.10, pp.5017-5024, 2001.

M. Cocquebert, S. Berndt, and N. Segond, Comparative expression of hCG -genes in human trophoblast from early and late first-trimester placentas, American Journal of Physiology-Endocrinology and Metabolism, vol.303, issue.8, pp.950-958, 2012.

E. Alsat, V. Mirlesse, C. Fondacci, M. Dodeur, and D. Evain-brion, Parathyroid hormone increases epidermal growth factor receptors in cultured human trophoblastic cells from early and term placenta, The Journal of Clinical Endocrinology & Metabolism, vol.73, issue.2, pp.288-295, 1991.

S. A. Degrelle, P. Gerbaud, L. Leconte, F. Ferreira, and G. Pidoux, Annexin-A5 organized in 2D-network at the plasmalemma eases human trophoblast fusion, Scientific Reports, vol.7, 2017.
URL : https://hal.archives-ouvertes.fr/inserm-02440462

J. Frendo, L. Cronier, and G. Bertin, Involvement of connexin 43 in human trophoblast cell fusion and differentiation, Journal of Cell Science, vol.116, issue.16, pp.3413-3421, 2003.
URL : https://hal.archives-ouvertes.fr/inserm-00128436

T. Kanda, K. F. Sullivan, and G. M. Wahl, Histone-GFP fusion protein enables sensitive analysis of chromosome dynamics in living mammalian cells, Current Biology, vol.8, issue.7, pp.377-385, 1998.